JNJ-5515

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJNJ-5515
Drug Alias NamemGluR2 NAMmGlu2 negative allosteric modulators (Janssen Research and Development/NovAlix)JNJ-5515
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonists
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsMental DisordersDepressionNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovAliXJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsMental DisordersDepressionNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A